Imperial College London

Dr Sofia Pappa MD, Ph.D

Faculty of MedicineDepartment of Brain Sciences

Honorary Senior Lecturer







Charing Cross HospitalCharing Cross Campus





Dr Sofia Pappa is an Hon Senior Lecturer at the Division of Psychiatry, Imperial College London and a Specialty Lead in Mental Health for the National Institute for Health Research (NIHR). She also works as a Consultant Psychiatrist and Mood & Psychosis Research Lead at West London NHS Trust.

She has dual training in Neurology and Psychiatry and was awarded a European scholarship for the completion of her PhD. She subsequently obtained a fellowship for postdoctoral research at the Institute of Psychiatry, Kings College London, evaluating the neuromotor dysfunction in early psychosis.

Her research interests include neuropsychopharmacology and the management of affective and psychotic disorders. She has also a keen interest in the interface between physical and mental health, neuropsychiatry (particularly in movement and sleep disorders)  and patient involvement.  

Dr Pappa has received a number of awards and grants and has acted as Principal Investigator for several clinical trials. She has published in high impact journals and regularly reviews manuscripts for top ranked journals and NIHR  applications.

She has significant experience in teaching including in her role as Imperial Medical School Tutor and Associate Clinical Professor in Psychiatry, RUSM Medical School and in clinical management, having served as Clinical Lead for Adult Mental Health Services in the past.



Dewa L, Kalniunas A, Orleans-Foli S, et al., 2021, Detecting signs of deterioration in young patients with serious mental illness: a systematic review, Systematic Reviews, Vol:10, ISSN:2046-4053, Pages:1-8

O'Driscoll C, Shaikh M, Finamore C, et al., 2021, Profiles and trajectories of mental health service utilisation during early intervention in psychosis., Schizophr Res, Vol:237, Pages:47-53

Pappa S, Sakkas N, Sakka E, 2021, A year in review: sleep dysfunction and psychological distress in healthcare workers during the COVID-19 pandemic., Sleep Med

Mason K, Barnett J, Pappa S, 2021, Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate, Therapeutic Advances in Psychopharmacology, Vol:11, ISSN:2045-1253

Pungor K, Sanchez P, Pappa S, et al., 2021, The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophrenia, Bmc Psychiatry, Vol:21

More Publications